• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Outlook Therapeutics Inc (NQ: OTLK )

    7.560 +0.490 (+6.93%)
    Streaming Delayed Price Updated: 3:16 PM EDT, Jun 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 134,648
    Open 7.250
    Bid (Size) 7.540 (4)
    Ask (Size) 7.580 (3)
    Prev. Close 7.070
    Today's Range 7.230 - 7.670
    52wk Range 0.2002 - 12.85
    Shares Outstanding 23,405,637
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
    Outlook Therapeutics (NASDAQ: OTLK) has gained attention, with analysts forecasting an upside of over 500% based on the consensus price target. 
    Via MarketBeat
    OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
    OTLK stock results show that Outlook Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +1823.17%
    +1823.17%
    1 Month
    -4.91%
    -4.91%
    3 Month
    +11.50%
    +11.50%
    6 Month
    +1705.16%
    +1705.16%
    1 Year
    +327.12%
    +327.12%

    More News

    Read More
    Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
    Via InvestorPlace
    Insiders Buying Outlook Therapeutics And 2 Other Stocks
    Via Benzinga
    Gold Moves Lower; Lululemon Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Dow Dips 200 Points; Nike Shares Fall After Q3 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 of the Best Speculative Stocks You Can Snag for Less Than $1
    Via InvestorPlace
    7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    OTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK
    From The Rosen Law Firm, P.A.
    Via Business Wire
    OTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    OTLK DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
    From The Rosen Law Firm PA
    Via GlobeNewswire
    OTLK DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    OUTLOOK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    OTLK DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    OTLK DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.